Please do not leave this page until complete. This can take a few moments.
Three Central Massachusetts manufacturing firms were among 11 companies to split $2.2 million in grants from the Massachusetts Manufacturing Accelerate Program, administered by the Center for Advanced Manufacturing at MassTech Collaborative.
Massachusetts Biomedical Initiatives in Worcester, a life science incubator, has been selected by the U.S. Small Business Administration as a stage two winner of its 2023 Growth Accelerator Fund Competition.
CVS Health, headquartered in Woonsocket, Rhode Island, has named Boston Scientific Chairman and CEO Michael Mahoney to its board of directors, effective November 1.
The U.S. Department of Defense on Wednesday chose Massachusetts to lead a regional microelectronics hub, positioning the state for growth in a burgeoning industry that the Healey administration hopes will reach a level of significance akin to the
Ascend Elements is planning to move its headquarters and research-and-development facility from Westborough to Devens in September 2024.
Aspen Aerogels, a Northborough battery technology company serving the electric vehicle and electric infrastructure industries, tapped Santhosh Daniel as its next chief accounting officer.
Rentschler Biopharma hired Tom Roberts as its first president of Milford-based U.S. operations, which is undergoing an historic expansion.
Marlborough-based medical technology giant Boston Scientific has agreed to acquire Relievant Medsystems, which has developed a proprietary technology to treat lower-back pain.
Shannon O’Brien, chair of the Massachusetts Cannabis Control Commission, has been suspended from her role.
Physik Instrumente appeared before the Town of Shrewsbury Select Board on Wednesday, requesting a tax break to relocate its U.S. division headquarters from Auburn to Shrewsbury.
New Jersey-based Goya Foods has opened a new 130,000-square-foot facility at its regional operations campus in Webster.
The Worcester incubator received a $375,000 grant from one of its successful graduate companies toward MBI’s $6-million goal to build out a biomanufacturing center.
Arch Therapeutics, a Framingham-based company specializing in wound care and biosurgical products, raised $2.6 million in bridge funding ahead of an intended uplisting of company stock.
As executive director of the Cannabis Control Commission, Shawn Collins is in the driver's seat of a newly empowered regulatory agency, one that oversees an industry that's still finding its footing and provides regulators with a parade of heady i
Marlborough medical device titan Boston Scientific received approval from the U.S. Food and Drug Administration for an upgrade to its WATCHMAN technology, which is designed to reduce the risk of strokes in patients.
Adult-use marijuana gross sales have crested $5 billion at Massachusetts establishments. Sales passed the milestone on Aug. 31.